Inhibitor of Apoptosis Protein-Like Protein-2 as a Novel Serological Biomarker for Breast Cancer
Inhibitor of apoptosis protein-like protein-2 (ILP-2) has only been detected in the testis and in lymphoblastoid cells. Although previous studies have not reported the presence of ILP-2 in breast cancer tissues, this study indicates the presence of ILP-2 in breast cancer serum samples. To validate w...
Main Authors: | Mingjun Xiang, Wei Zhou, Dandan Gao, Xiansong Fang, Qian Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2012-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/13/12/16737 |
Similar Items
-
Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosy
by: John S Spencer, et al.
Published: (2012-12-01) -
Evolução das vias de controle do desenvolvimento tecidual em holometábolos
by: Monfardini, Raquel Dietsche
Published: (2018) -
High‐throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype‐specific serologically relevant biomarkers
by: Thilde Terkelsen, et al.
Published: (2021-02-01) -
Annotation Concept Synthesis and Enrichment Analysis: a Logic-Based Approach to the Interpretation of High-Throughput Biological Experiments
by: Jiline, Mikhail
Published: (2011) -
Annotation Concept Synthesis and Enrichment Analysis: a Logic-Based Approach to the Interpretation of High-Throughput Biological Experiments
by: Jiline, Mikhail
Published: (2011)